CORTEZ, Guillermo S.,JOSEPH, Sajan,MCLEAN, Johnathan Alexander,MCMILLEN, William T.,RODRIGUEZ, Michael John,ZHAO, Gaiying
申请号：
TN2017000233
公开号：
TN2017000233A1
申请日:
2015.12.16
申请国别(地区):
TN
年份:
2018
代理人:
摘要：
The present invention provides thieno[2,3-c]pyrrol-4-one compounds that inhibit activity of extracellular-signal-regulated kinase (ERK) and may be useful in the treatment of cancer.
